Title: Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase. | Journal: Bioorganic & medicinal chemistry letters. 2010 May;20(9):2828-31 | Authors: Ronkin SM, Badia M, Bellon S, Grillot AL, Gross CH, Grossman TH, Mani N, Parsons JD, Stamos D, Trudeau M, Wei Y, Charifson PS. | Abstract: Bacterial DNA gyrase is an attractive target for the investigation of new antibacterial agents. Inhibitors of the GyrB subunit, which contains the ATP-binding site, are described in this communication. Novel, substituted 5-(1H-pyrazol-3-yl)thiazole compounds were identified as inhibitors of bacterial gyrase. Structure-guided optimization led to greater enzymatic potency and moderate antibacterial potency. Data are presented for the demonstration of selective enzyme inhibition of Escherichia coli GyrB over Staphylococcus aureus GyrB. | See full PubMed entry: http://www.ncbi.nlm.nih.gov/pubmed/20356737 |
|